Replimune (REPL) Shares Outstanding (2018 - 2025)
Replimune has reported Shares Outstanding over the past 8 years, most recently at $79.6 million for Q4 2025.
- Quarterly results put Shares Outstanding at $79.6 million for Q4 2025, up 3.4% from a year ago — trailing twelve months through Dec 2025 was $79.6 million (up 3.4% YoY), and the annual figure for FY2025 was $77.1 million, up 25.51%.
- Shares Outstanding reached $79.6 million in Q4 2025 per REPL's latest filing, up from $78.4 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $79.6 million in Q4 2025 and bottomed at $46.6 million in Q1 2021.
- Median Shares Outstanding over the past 5 years was $59.0 million (2023), compared with a mean of $60.7 million.
- The largest annual shift saw Shares Outstanding rose 26.99% in 2021 before it grew 1.66% in 2022.
- Over 5 years, Shares Outstanding stood at $47.2 million in 2021, then grew by 19.97% to $56.6 million in 2022, then grew by 8.4% to $61.4 million in 2023, then rose by 25.45% to $77.0 million in 2024, then increased by 3.4% to $79.6 million in 2025.
- Business Quant data shows Shares Outstanding for REPL at $79.6 million in Q4 2025, $78.4 million in Q3 2025, and $77.8 million in Q2 2025.